{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T12:46:52Z","timestamp":1778849212148,"version":"3.51.4"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>This article aims to analyze the trends in global thyroid cancer mortality rate (ASMR) and disability adjusted life years (DALYs) from 1990 to 2021, and predict changes in disease burden by 2030. Through global data comparison and analysis, this study explores the impact of gender, age, and socioeconomic development level (SDI) on thyroid cancer mortality and disease burden.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>This study is based on data from the Global Health Data Exchange (GHDx) and analyzes the trends of thyroid cancer deaths, age-standardized mortality rate (ASMR), and DALYs over the period from 1990 to 2021. The annual average rate of change (EAPC) of the data was analyzed using a joinpoint regression model. Additionally, stratified analyses were conducted by gender, age group, and SDI, and the burden of thyroid cancer for the year 2030 was projected.<\/jats:p><\/jats:sec><jats:sec><jats:title>Result<\/jats:title><jats:p>Global thyroid cancer deaths increased from 2,198 in 1990 to 5,255 in 2021. Despite the rise in total deaths, ASMR remained stable at 0.07\/100,000 for females and 0.05\/100,000 for males. DALYs increased from 61,815 to 144,955, with an average annual growth rate of 0.38%. The burden on men rose significantly, while the increase was slower for women. Regions with higher SDI showed a slight decrease in burden, whereas low-SDI regions saw an increase, with an annual growth rate of 0.76%. Fiji had the highest burden, with an ASMR of 0.25 and AS-DALYs of 6.07. Female mortality and disease burden were higher than in males, particularly among those aged 85 and above.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The global disease burden of thyroid cancer has been increasing, particularly in the older adult. While high-SDI regions experienced a decrease in burden, low-SDI regions saw an increase. Predictions suggest that by 2030, the mortality rate and disease burden may remain stable with slow annual changes. However, attention should be given to the growing burden in low-income areas and the impact of socio-economic factors.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2025.1626901","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:27:05Z","timestamp":1759123625000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Burden of thyroid cancer in the older adult aged 60 and over from 1990 to 2021 and forecast of the situation in 2030"],"prefix":"10.3389","volume":"15","author":[{"given":"Hanxu","family":"Fang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongshuai","family":"Bian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoran","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuling","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuzhen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingzeng","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuhai","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1366935","article-title":"Comparative analysis through propensity score matching in thyroid cancer: unveiling the impact of multiple Malignancies","volume":"15","author":"Al-Ibraheem","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/ncpendmet0022","article-title":"Long-term risks for thyroid cancer and other neoplasms after exposure to radiation","volume":"1","author":"Schneider","year":"2005","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"B3","article-title":"Thyroid disease in the elderly: sex-related differences in clinical expression","volume":"28","author":"Morganti","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.7150\/jca.24625","article-title":"Clinic-pathologic features and prognostic analysis of thyroid cancer in the older adult: A SEER based study","volume":"9","author":"Shi","year":"2018","journal-title":"J Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"04090","DOI":"10.7189\/jogh.14.04090","article-title":"Assessing and projecting the global burden of thyroid cancer, 1990-2030: Analysis of the Global Burden of Disease Study","volume":"14","author":"Zhao","year":"2024","journal-title":"J Glob Health"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1294441","article-title":"The relationship between subclinical hypothyroidism and invasive papillary thyroid cancer","volume":"14","author":"Li","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1308\/rcsann.2020.7064","article-title":"Prognosis of papillary thyroid carcinoma in relation to preoperative subclinical hypothyroidism","volume":"103","author":"Kang","year":"2021","journal-title":"Ann R Coll Surg Engl"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.abd.2021.02.004","article-title":"Assessment of thyroid disorders in patients with rosacea: a large case-control study","volume":"96","author":"Akin Belli","year":"2021","journal-title":"Bras Dermatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-023-02087-3","article-title":"Ultrasound screening for thyroid nodules and cancer in individuals with family history of thyroid cancer: a micro-costing approach","volume":"46","author":"Grani","year":"2023","journal-title":"J Endocrinol Invest"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(89)90951-6","article-title":"Radiation induced thyroid neoplasms 1920 to 1987: a vanishing problem","volume":"16","author":"Mehta","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2013.14.3.501","article-title":"Diffuse thyroid uptake incidentally found on 18F-fluorodeoxyglucose positron emission tomography in subjects without cancer history","volume":"14","author":"Lee","year":"2013","journal-title":"Korean J Radiol"},{"key":"B12","article-title":"A clinical study on coincidence with hyperthyroidism and thyroid carcinoma","volume":"22","author":"Lian","year":"2000","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1299741","article-title":"Thyroid cancer in patients with hyperthyroidism","volume":"44","author":"Pazaitou-Panayiotou","year":"2012","journal-title":"Horm Metab Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1530\/EJE-08-0468","article-title":"Mortality from thyroid cancer in patients with hyperthyroidism: the Theagenion Cancer Hospital experience","volume":"159","author":"Pazaitou-Panayiotou","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.955358","article-title":"Burden of thyroid cancer in North Africa and Middle East 1990\u20132019","volume":"12","author":"Nejadghaderi","year":"2022","journal-title":"Front Oncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"04131","DOI":"10.7189\/jogh.14.04131","article-title":"Thyroid cancer trends in China and its comparative analysis with G20 countries: Projections for 2020\u20132040","volume":"14","author":"Gong","year":"2024","journal-title":"J Glob Health"},{"key":"B17","doi-asserted-by":"publisher","first-page":"13231","DOI":"10.1038\/s41598-022-17115-0","article-title":"National, sub-national, and risk-attributed burden of thyroid cancer in Iran from 1990 to 2019","volume":"12","author":"Azangou-Khyavy","year":"2022","journal-title":"Sci Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000118752.34052.b7","article-title":"Latency period of thyroid neoplasia after radiation exposure","volume":"239","author":"Kikuchi","year":"2004","journal-title":"Ann Surg"},{"key":"B19","doi-asserted-by":"publisher","first-page":"929091","DOI":"10.3389\/fendo.2022.929091","article-title":"What is the status of immunotherapy in thyroid neoplasms","volume":"13","author":"Garcia-Alvarez","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.22.2469","article-title":"Risk factors for mortality in middle-aged women","volume":"166","author":"Tice","year":"2006","journal-title":"Arch Intern Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/2054-3581-1-10","article-title":"Mortality risk for women on chronic hemodialysis differs by age","volume":"1","author":"Sood","year":"2014","journal-title":"Can J Kidney Health Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112137-20240417-00909","article-title":"Rethinking on the epidemic situation and standardized diagnosis and treatment of low risk differentiated thyroid cancer","volume":"104","author":"Qin","year":"2024","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1001\/archoto.2010.55","article-title":"Thyroid cancer survival in the United States: observational data from 1973 to 2005","volume":"136","author":"Davies","year":"2010","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2006.04.026","article-title":"Variation in relative survival of thyroid cancers in Europe: results from the analysis on 21 countries over the period 1983-1994 (EUROCARE-3 study)","volume":"42","author":"Colonna","year":"2006","journal-title":"Eur J Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"20420188221090012","DOI":"10.1177\/20420188221090012","article-title":"The global burden of thyroid cancer in high-income Asia-Pacific: a systematic analysis of the Global Burden of Disease study","volume":"13","author":"Li","year":"2022","journal-title":"Ther Adv Endocrinol Metab"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.14099","article-title":"Global burden of thyroid cancer and its attributable risk factors in 204 countries and territories from 1990 to 2019","volume":"12","author":"Bao","year":"2021","journal-title":"Thorac Cancer"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3970","article-title":"The global burden of thyroid cancer and its attributable risk factor in 195 countries and territories: A systematic analysis for the Global Burden of Disease Study","volume":"10","author":"Zhai","year":"2021","journal-title":"Cancer Med"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1626901\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:27:06Z","timestamp":1759123626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1626901\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":27,"alternative-id":["10.3389\/fonc.2025.1626901"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1626901","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"article-number":"1626901"}}